Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 0.863 USD -0.3% Market Closed
Market Cap: 66.7m USD

Intrinsic Value

CLSD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CLSD stock under the Base Case scenario is 0.563 USD. Compared to the current market price of 0.863 USD, Clearside Biomedical Inc is Overvalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLSD Intrinsic Value
0.563 USD
Overvaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Clearside Biomedical Inc

Valuation History Unavailable

Historical valuation for CLSD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Clearside Biomedical Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clearside Biomedical Inc

Current Assets 16m
Cash & Short-Term Investments 13.6m
Receivables 1.5m
Other Current Assets 798k
Non-Current Assets 3.7m
PP&E 3.7m
Other Non-Current Assets 30k
Efficiency

Free Cash Flow Analysis
Clearside Biomedical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Clearside Biomedical Inc

Revenue
3.8m USD
Cost of Revenue
-397k USD
Gross Profit
3.4m USD
Operating Expenses
-29.2m USD
Operating Income
-25.9m USD
Other Expenses
-4.9m USD
Net Income
-30.8m USD
Fundamental Scores

CLSD Profitability Score
Profitability Due Diligence

Clearside Biomedical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional ROE
ROE is Increasing
32/100
Profitability
Score

Clearside Biomedical Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

CLSD Solvency Score
Solvency Due Diligence

Clearside Biomedical Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Clearside Biomedical Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

There are no price targets for CLSD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Clearside Biomedical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CLSD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CLSD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CLSD stock?

The intrinsic value of one CLSD stock under the Base Case scenario is 0.563 USD.

Is CLSD stock undervalued or overvalued?

Compared to the current market price of 0.863 USD, Clearside Biomedical Inc is Overvalued by 35%.

Back to Top